BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/24/2026 10:01:07 AM | Browse: 3 | Download: 0
Publication Name World Journal of Experimental Medicine
Manuscript ID 116584
Country Japan
Category Allergy
Manuscript Type Clinical Trials Study
Article Title Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms
Manuscript Source Invited Manuscript
All Author List Fumihiko Katagiri, Saori Hatoyama-Tanaka, Tetsuo Watanabe, Risa Takayanagi, Masashi Suzuki and Yasuhiko Yamada
Funding Agency and Grant Number
Corresponding Author Fumihiko Katagiri, Lecturer, PhD, Department of Clinical Evaluation of Drug Efficacy, Tokyo University of Pharmacy and Life Sciences, 1432-1, Horinouchi, Hachioji, Tokyo 192-0392, Tōkyō, Japan. katagiri@toyaku.ac.jp
Key Words Allergic rhinitis; Cedar pollinosis; Histamine H1 receptor antagonist; Nasal blockage; Nasal secretions; Olopatadine hydrochloride; Rhinorrhea; Sneezing; Substance P; Symptoms
Core Tip Olopatadine hydrochloride (olopatadine), a histamine H1 receptor antagonist, is used to treat various allergic diseases. It has been reported that the concentration of substance P (SP) in the nasal secretions of patients with pollinosis is higher than that of healthy individuals. Furthermore, it has been reported that olopatadine inhibits release of SP. In this study, we found that olopatadine reduces the concentration of SP in the nasal secretions of patients with pollinosis, suggesting that olopatadine reduces SP concentrations and may therefore contribute to improvement in symptoms.
Citation Katagiri F, Tanaka SH, Watanabe T, Takayanagi R, Suzuki M, Yamada Y. Effects of olopatadine hydrochloride on substance P concentrations in nasal secretions and nasal symptoms. World J Exp Med 2026; In press
Received
2025-11-17 04:24
Peer-Review Started
2025-11-17 04:24
First Decision by Editorial Office Director
2026-01-07 02:13
Return for Revision
2026-01-07 02:13
Revised
2026-01-20 06:19
Publication Fee Transferred
Second Decision by Editor
2026-02-24 02:45
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-24 10:01
Articles in Press
2026-02-24 10:01
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com